Nitin Mehta

About The Modern Data Company DataOS® from The Modern Data Company is a groundbreaking data operating system that radically simplifies the intricacies of data. Treating data as software, it empowers organizations to build comprehensive data products that drive outcome-based, trusted decisions. Seamlessly integrating with any existing data architecture, DataOS® provides a unified and composable data ecosystem. This facilitates the smooth integration and operationalization of data products at scale, ensuring business processes remain uninterrupted. It enables cross-organizational data collaboration that is not only safer but also more efficient than ever before. Dive into the transformative world of data products to future-proof your data initiatives. Learn more at TheModernDataCompany.com.

Retrotope‘s proprietary drug platform represents a breakthrough in the treatment of degenerative diseases. Research has established a link between the oxidative damage of lipids in mitochondrial membranes and neurodegeneration in Parkinson’s, Alzheimer’s, Friedreich’s ataxia and other diseases. Retrotope’s first drug candidate, RT001, confers cell protection against oxidative stress in high energy tissues like brain, retina and heart tissue by inhibiting mitochondrial lipid peroxidation. Its mechanism of action has been shown not only to prevent further cellular damage but also to recover mitochondrial function. RT001’s molecular structure is so similar to ordinary fats that the body naturally distributes them throughout the tissues wherever they are needed. The drug has been determined safe in human trials in a recent Phase 1/2 clinical trial in Friedreich’s ataxia patients. Retrotope is a privately held company founded and backed by world—renowned scientists, entrepreneurs, and investors. The company founders have dozens of years of experience in drug discovery technologies, a member of the US National Academy of Sciences, and several successful startups among them. Retrotope has developed its science virtually, with over 50 collaborations at major centers of excellence around the world that have yielded insights into the mechanisms of several diseases.

Webex is a leading provider of cloud-based collaboration solutions which includes video meetings, calling, messaging, events, customer experience solutions like contact center and purpose-built collaboration devices. At Webex, we start with people and their experiences first. This focus on delivering inclusive collaboration experiences fuels our innovation, which leverages AI and Machine Learning, to remove the barriers of geography, language, personality, and familiarity with technology. Our solutions are underpinned with security and privacy by design. We work with the world’s leading business and productivity apps – delivered through a single application and interface. Learn more at webex.com

About The Modern Data Company DataOS® from The Modern Data Company is a groundbreaking data operating system that radically simplifies the intricacies of data. Treating data as software, it empowers organizations to build comprehensive data products that drive outcome-based, trusted decisions. Seamlessly integrating with any existing data architecture, DataOS® provides a unified and composable data ecosystem. This facilitates the smooth integration and operationalization of data products at scale, ensuring business processes remain uninterrupted. It enables cross-organizational data collaboration that is not only safer but also more efficient than ever before. Dive into the transformative world of data products to future-proof your data initiatives. Learn more at TheModernDataCompany.com.

Retrotope‘s proprietary drug platform represents a breakthrough in the treatment of degenerative diseases. Research has established a link between the oxidative damage of lipids in mitochondrial membranes and neurodegeneration in Parkinson’s, Alzheimer’s, Friedreich’s ataxia and other diseases. Retrotope’s first drug candidate, RT001, confers cell protection against oxidative stress in high energy tissues like brain, retina and heart tissue by inhibiting mitochondrial lipid peroxidation. Its mechanism of action has been shown not only to prevent further cellular damage but also to recover mitochondrial function. RT001’s molecular structure is so similar to ordinary fats that the body naturally distributes them throughout the tissues wherever they are needed. The drug has been determined safe in human trials in a recent Phase 1/2 clinical trial in Friedreich’s ataxia patients. Retrotope is a privately held company founded and backed by world—renowned scientists, entrepreneurs, and investors. The company founders have dozens of years of experience in drug discovery technologies, a member of the US National Academy of Sciences, and several successful startups among them. Retrotope has developed its science virtually, with over 50 collaborations at major centers of excellence around the world that have yielded insights into the mechanisms of several diseases.

Webex is a leading provider of cloud-based collaboration solutions which includes video meetings, calling, messaging, events, customer experience solutions like contact center and purpose-built collaboration devices. At Webex, we start with people and their experiences first. This focus on delivering inclusive collaboration experiences fuels our innovation, which leverages AI and Machine Learning, to remove the barriers of geography, language, personality, and familiarity with technology. Our solutions are underpinned with security and privacy by design. We work with the world’s leading business and productivity apps – delivered through a single application and interface. Learn more at webex.com

TiE Inc, also known as TiE Global is a non-profit organization with the mission of fostering entrepreneurship, through mentoring, networking and education. Members of TiE attend meetings at various chapters, exchange ideas and build partnerships to start new companies or ventures. http://www.tie.org